<DOC>
	<DOCNO>NCT01414803</DOCNO>
	<brief_summary>Although combination statin fenofibrate one option patient combine hyperlipidemia , non-lipid effect completely understood yet . In study compare effect rosuvastatin 10 mg/fenofibrate 160 mg combination rosuvastatin 10 mg monotherapy muscle liver enzyme , homocysteine level , kidney , blood glucose control , blood cell count .</brief_summary>
	<brief_title>Tolerability Efficacy Rosuvastatin - Fenofibrate Combine Therapy Korean Patients With Combined Hyperlipidemia</brief_title>
	<detailed_description />
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>mixed hyperlipidemia : total cholesterol level higher 220 mg/dL , triglyceride ( TG ) level 200 500 mg/dL , lowdensity lipoprotein ( LDL ) cholesterol level higher 130 mg/dL 6week diet/life style change Men woman 20 70 year age Having least one history : coronary artery disease , cerebrovascular disease transient ischemic attack , peripheral vascular disease , diabetes mellitus . Having risk factor least two : age ≥45 year male ≥55 year female , elevate blood pressure ( systolic blood pressure ≥130 mmHg diastolic blood pressure ≥85 mmHg , treatment previously diagnose hypertension ) , highdensity lipoprotein ( HDL ) cholesterol &lt; 40 mg/dL , family history coronary artery disease age &lt; 55 year male &lt; 65 year female , central obesity ( waist circumference ≥90 cm male ≥80 cm female ) , fast plasma glucose ≥110 mg/dL , leave ventricular hypertrophy electrocardiogram Written inform consent . pregnant breastfeeding uncontrolled hypertension uncontrolled diabetes mellitus thyroid dysfunction serum transaminase level &gt; 2 time upper limit normal history gall bladder disease chronic alcoholic serum creatinine level &gt; 1.5 mg/dL history myopathy history acute myocardial infarction acute stroke within 3 month study begin acute chronic infection inflammation history cancer history adverse event associate test drug .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>rosuvastatin , fenofibrate , creatine kinase , alanine aminotransferase</keyword>
</DOC>